Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 2, 2011, Pages 253-260

  Findeisen, Hannes M ^a   Gizard, Florence ^a   Zhao, Yue ^a   Cohn, Dianne ^a   Heywood, Elizabeth B ^a   Jones, Karrie L ^a   Lovett, David H ^b   Howatt, Deborah A ^a   Daugherty, Alan ^a   Bruemmer, Dennis ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aneurysms; angiotensin II; gene expression; macrophages; matrix metalloproteinase; telomerase

Indexed keywords

ANGIOTENSIN II; GELATINASE A; LOW DENSITY LIPOPROTEIN RECEPTOR; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CHOLESTEROL DIET; CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENOTYPE; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CELLS, CULTURED; ELASTIN; GENOTYPE; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTORS, LDL; TELOMERASE; TELOMERE;

EID: 79551473928     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.218545     Document Type: Article

References (50)

1. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services task force. Ann Intern Med. 2005;142:203-211.
2. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneu-rysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605-2613.
3. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:1621-1626.
4. Rizas KD, Ippagunta N, Tilson MDI. Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev. 2009;17:201-210.
5. Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation. 2008; 118:2382-2392.
6. Atturu G, Brouilette S, Samani NJ, London NJM, Sayers RD, Bown MJ. Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2010;39:559-564.
7. Wilson WRW, Herbert KE, Mistry Y, Stevens SE, Patel HR, Hastings RA, Thompson MM, Williams B. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J. 2008;29:2689-2694.
8. Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106: 661-673.
9. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998; 279:349-352.
10. Masutomi K, Possemato R, Wong JMY, Currier JL, Tothova Z, Manola JB, Ganesan S, Lansdorp PM, Collins K, Hahn WC. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA. 2005;102:8222-8227.
11. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, Cheung P, Jun S, Artandi MK, Shah N, Kim SK, Artandi SE. Tert promotes epithelial proliferation through transcriptional control of a myc-and wnt-related developmental program. PLoS Genet. 2008;4:e10.
12. Park J-I, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460:66-72.
13. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (HTERT). Gene. 2001; 269:1-12.
14. Liu S-C, Wang S-S, Wu M-Z, Wu D-C, Yu F-J, Chen W-J, Chiang F-T, Yu M-F. Activation of telomerase and expression of human telomerase reverse transcriptase in coronary atherosclerosis. Cardiovasc Pathol. 2005;14:232-240.
15. Narducci ML, Grasselli A, Biasucci LM, Farsetti A, Mule A, Liuzzo G, La Torre G, Niccoli G, Mongiardo R, Pontecorvi A, Crea F. High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol. 2007;50:2369-2374.
16. Weng N-P, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA. 1997;94:10827-10832.
17. Herrera E, Martinez-A C, Blasco MA. Impaired germinal center reaction in mice with short telomeres. EMBO J. 2000;19:472-481.
18. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient at1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:380-386.
19. Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, Daugherty A. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg. 2006;44:372-376.
20. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL, Daugherty A. Ang ii infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol. 2009;296:H1660-H1665.
21. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-1612.
22. Cawthon RM. Telomere measurement by quantitative PCR. Nucl. Acids Res. 2002;30:e47.
23. Nakamachi T, Nomiyama T, Gizard F, Heywood EB, Jones KL, Zhao Y, Fuentes L, Takebayashi K, Aso Y, Staels B, Inukai T, Bruemmer D. PPARa agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes. 2007; 56:1662-1670.
24. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with junb-fra1 and junb-fosb heterodimers. Biochem J. 2003;369:485-496.
25. Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K, Nakamura T, Kiyono T, Toguchida J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun. 2002;295:354-361.
26. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem. 1991;266:7870-7875.
27. Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg. 2007;45: 849-857.
28. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.
29. Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul study. Arterioscler Thromb Vasc Biol. 2008;28:1379-1384.
30. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369: 107-114.
31. Aviv A. Leukocyte telomere length, hypertension, and atherosclerosis: are there potential mechanistic explanations? Hypertension. 2009;53: 590-591.
32. Bischoff C, Petersen HC, Graakjaer J, Andersen-Ranberg K, Vaupel JW, Bohr VA, Kolvraa S, Christensen K. No association between telomere length and survival among the elderly and oldest old. Epidemiology. 2006;17:190-194.
33. Martin-Ruiz CM, Gussekloo J, Heemst D, Zglinicki T, Westendorp RGJ. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell. 2005; 4:287-290.
34. Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, Klinenberg JR, Linker-Israeli M. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive cd8+cd28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol. 2001;99:211-221.
35. Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takagi S, Maekawa H, Toyota T. Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol. 1998;33:343-348.
36. Ilmonen P, Kotrschal A, Penn DJ. Telomere attrition due to infection. PLoS ONE. 2008;3:e2143.
37. Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama Ji, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N, Ishikawa F. Presence of telomeric G-strand tails in the telomerase catalytic subunit tert knockout mice. Genes Cells. 1999;4:563-572.
38. Lee H-W, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569-574.
39. Sahin E, DePinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010;464:520-528.
40. Samper E, Fernandez P, Eguia R, Martin-Rivera L, Bernad A, Blasco MA, Aracil M. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood. 2002;99:2767-2775.
41. Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 2003;102:517-520.
42. Cong Y, Shay JW. Actions of human telomerase beyond telomeres. Cell Res. 18:725-732.
43. Young JI, Sedivy JM, Smith JR. Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I. J Biol Chem. 2003;278:19904-19908.
44. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol. 2003;5:474-479.
45. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15: 1145-1151.
46. Martens JW, Sieuwerts AM, Bolt-deVries J, Bosma PT, Swiggers SJ, Klijn JG, Foekens JA. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb Haemost. 2003; 89:393-404.
47. Akiyama M, Hideshima T, Hayashi T, Tai Y-T, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Nuclear factor- KB p65 mediates tumor necrosis factor a-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 2003;63: 18-21.
48. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 2005;65:7585-7590.
49. Chernov AV, Sounni NE, Remacle AG, Strongin AY. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J Biol Chem. 2009;284:12727-12734.
50. Wu B, Crampton SP, Hughes CCW. Wnt signaling induces matrix met-alloproteinase expression and regulates t cell transmigration. Immunity. 2007;26:227-239.